
Phaarmasia Ltd Hits New 52-Week High at Rs.131.75 on 12 Jan 2026
2026-01-12 12:04:13Phaarmasia Ltd has reached a significant milestone by hitting a new 52-week high of Rs.131.75 today, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector. This achievement underscores the stock’s sustained upward trajectory over recent weeks, outpacing sector performance and demonstrating strong investor confidence in its current valuation.
Read full news article
Phaarmasia Ltd Hits New 52-Week High at Rs.129.2
2026-01-09 11:13:09Phaarmasia Ltd has surged to a fresh 52-week high of Rs.129.2, reflecting a robust rally that has propelled the stock to outperform its sector and demonstrate sustained upward momentum over the past fortnight.
Read full news article
Phaarmasia Ltd Hits New 52-Week High of Rs.126.7 on 8 Jan 2026
2026-01-08 14:35:47Phaarmasia Ltd has surged to a fresh 52-week high of Rs.126.7, reflecting a robust rally that has propelled the stock to outperform its sector and demonstrate sustained upward momentum over the past several trading sessions.
Read full news article
Phaarmasia Ltd Hits New 52-Week High at Rs.122.2 on 7 Jan 2026
2026-01-07 10:43:04Phaarmasia Ltd has reached a significant milestone by hitting a new 52-week high of Rs.122.2 today, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector. This achievement comes after a sustained rally, with the stock gaining 15.01% over the past eight consecutive trading sessions.
Read full news article
Phaarmasia Ltd Hits New 52-Week High at Rs.121.85 on 6 Jan 2026
2026-01-06 10:46:21Phaarmasia Ltd has surged to a fresh 52-week high of Rs.121.85, reflecting a robust rally that has propelled the stock to outperform its sector and demonstrate sustained upward momentum over the past week.
Read full news article
Phaarmasia Ltd is Rated Hold by MarketsMOJO
2026-01-06 10:10:10Phaarmasia Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 18 Nov 2025. While the rating change occurred on that date, the analysis and financial metrics presented here reflect the stock's current position as of 06 January 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Phaarmasia Ltd Hits New 52-Week High of Rs.119.5 on 5 Jan 2026
2026-01-05 10:46:16Phaarmasia Ltd surged to a fresh 52-week high of Rs.119.5 on 5 Jan 2026, reflecting robust upward momentum in the Pharmaceuticals & Biotechnology sector. The stock has demonstrated sustained gains over the past week, outperforming its sector peers and trading well above key moving averages.
Read full news article
Phaarmasia Ltd Hits New 52-Week High of Rs.117.2 on 2 Jan 2026
2026-01-02 10:42:45Phaarmasia Ltd has surged to a fresh 52-week high of Rs.117.2, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector. This milestone underscores the stock’s impressive rally, driven by sustained gains and favourable market conditions.
Read full news article
Phaarmasia Ltd Hits New 52-Week High of Rs.114.95 on 1 Jan 2026
2026-01-01 10:46:40Phaarmasia Ltd has reached a significant milestone by hitting a new 52-week high of Rs.114.95 today, reflecting robust momentum in the Pharmaceuticals & Biotechnology sector. This achievement underscores the stock’s strong performance over the past year, outpacing broader market indices and sector peers.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
16-Jan-2026 | Source : BSECertificate under Reg 74(5) of SEBI(Depositories and Participants) Regulations 2018 for the Quarter ended 31st December 2025
Closure of Trading Window
29-Dec-2025 | Source : BSEClosure of trading Window for dealing in the securities of the company will remain closed from January 01st 2026 till 48hrs of the declaration of unaudited Financial Statements for the Quarter ended December 31st 2025.
Announcement under Regulation 30 (LODR)-Newspaper Publication
15-Nov-2025 | Source : BSENewspaper Publication of the Unaudited Financial Results for the Quarter and Half Year Ended 30th September 2025.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






